about
Increased end-stage diabetic nephropathy in Indo-Asian immigrants living in the Netherlands.Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) studyStreptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases.Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 casesPreferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases.Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases.Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases.Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 cases.Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis.Recovery of renal function in end-stage renal failure--comparison between peritoneal dialysis and haemodialysis.Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients.Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases.Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis.Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes.Periodic limb movement disorder and restless legs syndrome in dialysis patients.Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand.The effect of low-dose dopamine on renal haemodynamics in patients with type 1 (insulin-dependent) diabetes does not differ from normal individuals.Encapsulating peritoneal sclerosis: incidence, predictors, and outcomesPredictors and outcomes of fungal peritonitis in peritoneal dialysis patientsAutomated and continuous ambulatory peritoneal dialysis have similar outcomesEffect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populationsEffect of intravenous infusion of low-dose dopamine on renal function in normal individuals and in patients with renal diseaseProspective randomised trial of early dietary protein restriction in chronic renal failureAcute renal failure due to diltiazemHigh membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysisEnterococcal peritonitis in peritoneal dialysis: the danger from within?Does the intravascular volume status in haemodialysis patients measured by inferior vena cava ultrasound correlate with bioimpedance spectroscopy?
P50
Q29354048-BCBE9F18-3628-4964-9DAB-7EB84C2FF773Q33401679-EDC7FD7F-FA25-4096-B8B9-C86728F60391Q33486767-84DDCCCA-BAE9-488D-B8AB-E8160061E234Q37176852-C6B6026D-5360-454A-AA3B-748E125D3732Q38871976-D02B4844-F9D3-4D12-B9ED-5FF737CD8D13Q39905622-F6BE7784-44D9-4320-B7DE-A7746ABDF5E1Q43064239-313F0D0F-4092-4061-83BA-06F30E0B2F95Q43147196-317BA4AB-F19C-4B3B-832B-E94F24A6338CQ43233472-6291D428-CBA5-43E9-9368-FD15773CDB7CQ43627978-70AE6918-D205-4DC4-AE3D-FD9A570B9A26Q43905155-B6CBFF55-7C8C-4A08-92F7-633A449D3A16Q44228618-D81A4F91-8CF5-45AD-8404-07F7450A5B24Q44372591-E66D0F29-978B-48C7-B667-0919706484A5Q44429040-055C3EC1-6073-448B-A60C-6780541735E4Q44705449-F24E43D9-347E-4A02-93A6-6193E51C4C7EQ48565316-68065AA5-3C00-4FA1-B03F-643D14056900Q53044485-C1FBEFAA-83C7-467A-B813-12C8487116AEQ54433222-628E63F9-E3E4-42F0-939E-756CA0C5259FQ61524256-51CFB898-A751-45E8-87B0-48F0BDDDF5E4Q61524404-A8651DF3-853A-422A-A899-6892DB5DC87BQ61524464-137B8E5B-BC82-46F5-9952-EBDFF219B9CAQ61524618-E6B56AF9-8EFA-42FF-A91B-75786204565BQ70040405-4416D960-EB1D-4206-9A02-D720308143C7Q72594017-D4D0C65D-2F56-4FEA-9DFB-675E807E7F74Q72594133-CC3898C3-D79E-4024-90E4-E76AA17BDDCAQ80422227-95A39E71-377F-44A6-9221-4B01D47F9C22Q85049363-F9BBE34F-0DE5-4A88-B480-F1D2623D1E56Q91152940-45A4D682-B732-4604-8D5E-91D88BACB7E6
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Johan B. Rosman
@ast
Johan B. Rosman
@en
Johan B. Rosman
@es
Johan B. Rosman
@nl
Johan B. Rosman
@sl
type
label
Johan B. Rosman
@ast
Johan B. Rosman
@en
Johan B. Rosman
@es
Johan B. Rosman
@nl
Johan B. Rosman
@sl
prefLabel
Johan B. Rosman
@ast
Johan B. Rosman
@en
Johan B. Rosman
@es
Johan B. Rosman
@nl
Johan B. Rosman
@sl
P1053
D-5702-2013
P106
P1153
7003782095
P21
P31
P3829
P496
0000-0003-1587-8900